ebselen has been researched along with chelerythrine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bastianetto, S; Quirion, R; Zheng, WH | 1 |
Auld, DS; Boxer, MB; Ferraris, DV; Rojas, C; Shen, M; Simeonov, A; Slusher, BS; Tanega, C; Thomas, AG; Tsukamoto, T | 1 |
2 other study(ies) available for ebselen and chelerythrine
Article | Year |
---|---|
The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C.
Topics: Alkaloids; Alzheimer Disease; Animals; Antioxidants; Azoles; Benzophenanthridines; Brain Ischemia; Calcium Channel Blockers; Calcium Channels, L-Type; Cells, Cultured; Diterpenes; Enzyme Inhibitors; Estrenes; Flavonoids; Free Radical Scavengers; Ginkgo biloba; Ginkgolides; Hippocampus; Isoindoles; Lactones; Molsidomine; Neurons; Neuroprotective Agents; Nitrendipine; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Organoselenium Compounds; Oxidative Stress; Phenanthridines; Phosphodiesterase Inhibitors; Plant Extracts; Plants, Medicinal; Protein Kinase C; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Signal Transduction; Vasodilator Agents | 2000 |
Kinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitors.
Topics: AIDS Dementia Complex; Apomorphine; Azoles; Benzophenanthridines; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Glutaminase; Humans; Inhibitory Concentration 50; Isoindoles; Neoplasms; Organoselenium Compounds; RNA, Small Interfering; Sensitivity and Specificity | 2013 |